Merck & Co. has substantially cut the price of 2 of its antiretroviral agents in Mexico

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.315, 2001-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Merck & Co., Inc. has lowered its prices in developing countries for its 2 HIV drugs

Inpharma, Vol. 1, Iss. 1279, 2001-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Latin America is the latest region to benefit from Merck & Co.'s antiretroviral price cuts

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 318, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

The federal government in Australia has announced that Pfizer's atorvastatin [Lipitor] warrants a higher price than Merck & Co's simvastatin [Zocor] for Pharmaceutical Benefits Scheme (PBS) subsidy

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 483, 2005-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Merck Sharpe and Dohme has launched new formulations for all dosage strengths of its NSAID etoricoxib [Arcoxia]

Inpharma, Vol. 1, Iss. 1538, 2006-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Antiretroviral price reductions possible

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 514, 2006-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite